• Je něco špatně v tomto záznamu ?

Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space

M. Maly, T. Riedel, J. Stikarova, J. Suttnar, R. Kotlin, M. Hajsl, P. Tousek, J. Kaufmanova, O. Kucerka, JW. Weisel, JE. Dyr

. 2022 ; 122 (3) : 434-444. [pub] 20211115

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22010923

Grantová podpora
Ministry of Health, Czech Republic 00023736
Czech Science Foundation P205/12/G118
European Regional Development Fund and the state budget of the Czech Republic CZ.02.1.01/0.0/0.0/16_025/0007428
National Institutes of Health grant HL148227

We describe the internal structure, spatial organization and dynamic formation of coronary artery thrombi from ST-segment elevation myocardial infarction patients. Scanning electron microscopy (SEM) revealed significant differences among four groups of patients (<2 hours; 2-6 hours; 6-12 hours, and >12 hours) related to the time of ischemia. Coronary artery thrombi from patients presenting less than 2 hours after the infarction were almost entirely composed of platelets, with small amounts of fibrin and red blood cells. In contrast, thrombi from late presenters (>12 hours) consisted of mainly platelets at the distal end, where clotting was initiated, with almost no platelets at the proximal end, while the red blood cell content went from low at the initiating end to more than 90% at the proximal end. Furthermore, fibrin was present mainly on the outside of the thrombi and older thrombi contained thicker fibers. The red blood cells in late thrombi were compressed to a close-packed, tessellated array of polyhedral structures, called polyhedrocytes. Moreover, there was redistribution from the originally homogeneous composition to fibrin and platelets to the outside, with polyhedrocytes on the interior. The presence of polyhedrocytes and the redistribution of components are signs of in vivo clot contraction (or retraction). These results suggest why later thrombi are resistant to fibrinolytic agents and other treatment modalities, since the close-packed polyhedrocytes form a nearly impermeable seal. Furthermore, it is of particular clinical significance that these findings suggest specific disparate therapies that will be most effective at different stages of thrombus development.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010923
003      
CZ-PrNML
005      
20220506130210.0
007      
ta
008      
220425s2022 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1055/s-0041-1739193 $2 doi
035    __
$a (PubMed)34781375
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Maly, Martin $u First Faculty of Medicine, Department of Medicine, Charles University in Prague and Military University Hospital, Prague, Czech Republic
245    10
$a Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space / $c M. Maly, T. Riedel, J. Stikarova, J. Suttnar, R. Kotlin, M. Hajsl, P. Tousek, J. Kaufmanova, O. Kucerka, JW. Weisel, JE. Dyr
520    9_
$a We describe the internal structure, spatial organization and dynamic formation of coronary artery thrombi from ST-segment elevation myocardial infarction patients. Scanning electron microscopy (SEM) revealed significant differences among four groups of patients (<2 hours; 2-6 hours; 6-12 hours, and >12 hours) related to the time of ischemia. Coronary artery thrombi from patients presenting less than 2 hours after the infarction were almost entirely composed of platelets, with small amounts of fibrin and red blood cells. In contrast, thrombi from late presenters (>12 hours) consisted of mainly platelets at the distal end, where clotting was initiated, with almost no platelets at the proximal end, while the red blood cell content went from low at the initiating end to more than 90% at the proximal end. Furthermore, fibrin was present mainly on the outside of the thrombi and older thrombi contained thicker fibers. The red blood cells in late thrombi were compressed to a close-packed, tessellated array of polyhedral structures, called polyhedrocytes. Moreover, there was redistribution from the originally homogeneous composition to fibrin and platelets to the outside, with polyhedrocytes on the interior. The presence of polyhedrocytes and the redistribution of components are signs of in vivo clot contraction (or retraction). These results suggest why later thrombi are resistant to fibrinolytic agents and other treatment modalities, since the close-packed polyhedrocytes form a nearly impermeable seal. Furthermore, it is of particular clinical significance that these findings suggest specific disparate therapies that will be most effective at different stages of thrombus development.
650    _2
$a hemokoagulace $x účinky léků $x fyziologie $7 D001777
650    _2
$a trombocyty $x patologie $7 D001792
650    12
$a koronární trombóza $x diagnostické zobrazování $x farmakoterapie $x metabolismus $x patologie $7 D003328
650    _2
$a léková rezistence $x fyziologie $7 D004351
650    _2
$a erytrocyty $x patologie $7 D004912
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrin $x analýza $7 D005337
650    12
$a fibrinolytika $x aplikace a dávkování $x škodlivé účinky $7 D005343
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikroskopie elektronová rastrovací $x metody $7 D008855
650    _2
$a lidé středního věku $7 D008875
650    12
$a infarkt myokardu s elevacemi ST úseků $x etiologie $x terapie $7 D000072657
650    _2
$a trombektomie $x metody $7 D017131
650    _2
$a časové faktory $7 D013997
650    _2
$a čas zasáhnout při rozvinutí nemoci $7 D061665
655    _2
$a časopisecké články $7 D016428
700    1_
$a Riedel, Tomas $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Stikarova, Jana $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000259640526
700    1_
$a Suttnar, Jiri $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Kotlin, Roman $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Hajsl, Martin $u First Faculty of Medicine, Department of Medicine, Charles University in Prague and Military University Hospital, Prague, Czech Republic
700    1_
$a Tousek, Petr $u Cardiocenter, University Hospital Kralovske Vinohrady and Third Medical Faculty, Charles University, Prague, Czech Republic
700    1_
$a Kaufmanova, Jirina $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Prague, Czech Republic
700    1_
$a Kucerka, Ondrej $u First Faculty of Medicine, Department of Medicine, Charles University in Prague and Military University Hospital, Prague, Czech Republic
700    1_
$a Weisel, John W $u Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
700    1_
$a Dyr, Jan E $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
773    0_
$w MED00004517 $t Thrombosis and haemostasis $x 2567-689X $g Roč. 122, č. 3 (2022), s. 434-444
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34781375 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130202 $b ABA008
999    __
$a ok $b bmc $g 1788846 $s 1162121
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 122 $c 3 $d 434-444 $e 20211115 $i 2567-689X $m Thrombosis and haemostasis $n Thromb Haemost $x MED00004517
GRA    __
$a Ministry of Health, Czech Republic $p 00023736
GRA    __
$a Czech Science Foundation $p P205/12/G118
GRA    __
$a European Regional Development Fund and the state budget of the Czech Republic $p CZ.02.1.01/0.0/0.0/16_025/0007428
GRA    __
$a National Institutes of Health grant $p HL148227
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...